Shares of HIMS experienced a dramatic decline today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors responded negatively click here to the news, sending the company's stock price plummeting by more than 10%. The reason for the breakdown of the partnership remains unclear, but industry analys